510(k) Report

PMA · Approved

Approved

Bracanalysis CDX

P140020PMAApproved Dec 19, 201486-day reviewClass III

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Myriad Genetic Laboratories · PJG Cancer-Related Germline Gene Mutation Detection System

Approved on Dec 19, 2014 through premarket approval, which rests on the device’s own clinical evidence after an 86-day review.

Decided
Dec 19, 2014
Review
86 days
Class
Class III
Product code
PJG
Recalls
None

PMA approvals rest on their own clinical evidence and do not claim a predicate, so this family tree starts here.

P140020 has 25 supplements since 2015: changes to the approved device, its labelling or its manufacturing, each approved separately.

PMA supplements approved per year

2015: 22016: 52017: 32018: 52019: 22020: 12021: 12022: 32023: 22024: 1
2015high 5 (2016) · low 1 (2020)2024
View FIG. 1 as a table
YearSupplements approved
20152
20165
20173
20185
20192
20201
20211
20223
20232
20241
FIG. 1 — Supplements to P140020, 2015–2024Source: FDA PMA database

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA PMA database (decision fields and supplements), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in PJG? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

  • Candidate predicates for a device like this, rankedin the report
  • Recall history across each candidate’s familyin the report
Get a 510(k) Report

Does it have a predicate?

PMA decisions do not claim a predicate device.

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

How does its category compare?

All PJG devices

PJG Cancer-Related Germline Gene Mutation Detection System: FDA decisions, review times, recalls and adverse event reports over 20 years. 2014, this device’s year, is highlighted.

FDA decisions per year · PJG

2in 2024

2014: 12015: 22016: 52017: 32018: 52019: 32020: 12021: 32022: 52023: 12024: 22026 (partial year): 1
2007high 5 (2016) · low 0 (2007)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · PJG

Too few PJG 510(k)s in any year since 2007 to give a median.

Recalls per year · PJG

No recall names PJG since 2007.

Adverse event reports per year · PJG

1in 2022

2022: 1
2007high 1 (2022) · low 0 (2007)2025

MAUDE reports naming product code PJG, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20070—00
20080—00
20090—00
20100—00
20110—00
20120—00
20130—00
20141—00
20152—00
20165—00
20173—00
20185—00
20193—00
20201—00
20213—00
20225—01
20231—00
20242—00
20250—00
20261—0—
Cite this page

510(k) Report. “P140020: Bracanalysis CDX.” Lineage record from FDA PMA data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/P140020

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Page last updated Nov 3, 2026